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Exploring Antipsychotic Prescribing Behaviors for 1 
Nursing Home Residents With Dementia: A 2 
Qualitative Study 3 
Abstract 4 
Objectives:  5 
Caution is advised when prescribing antipsychotics to people with dementia. This study 6 
explored the determinants of appropriate, evidence-based antipsychotic prescribing 7 
behaviors for nursing home residents with dementia, with a view to informing future quality 8 
improvement efforts and behavior change interventions.   9 
Design:  10 
Semi-structured qualitative interviews based on the Theoretical Domains Framework (TDF).  11 
Setting and participants:  12 
A purposive sample of 27 participants from 4 nursing homes, involved in the care of nursing 13 
home residents with dementia (8 nurses, 5 general practitioners, 5 healthcare assistants, 3 14 
family members, 2 pharmacists, 2 consultant geriatricians and 2 consultant psychiatrists of 15 
old age) in a Southern region of Ireland.  16 
 17 
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Measures:  18 
Using Framework Analysis, the predominant TDF domains and determinants influencing 19 
these behaviors were identified, and explanatory themes developed. 20 
Results: 21 
Nine predominant TDF domains were identified as influencing appropriate antipsychotic 22 
prescribing behaviors. Participants’ effort to achieve “a fine balance” between the risks and 23 
benefits of antipsychotics was identified as the cross-cutting theme that underpinned many 24 
of the behavioral determinants. On one hand, neither healthcare workers nor family 25 
members wanted to see residents over-sedated and without a quality of life. Conversely, 26 
the reality of needing to protect staff, family members and residents from potentially 27 
dangerous behavioral symptoms, in a resource-poor environment, was emphasized. The 28 
implementation of best-practice guidelines was illustrated through three explanatory 29 
themes (‘human suffering’; ‘the interface between resident and nursing home’; and ‘power 30 
and knowledge: complex stakeholder dynamics’) which conceptualize how different nursing 31 
homes strike this “fine balance”. 32 
Conclusions: 33 
Implementing evidence-based antipsychotic prescribing practices for nursing home 34 
residents with dementia remains a significant challenge. Greater policy and institutional 35 
support is required to help stakeholders strike that “fine balance” and ultimately make 36 
better prescribing decisions. This study has generated a deeper understanding of this 37 
complex issue and will inform the development of an evidence-based intervention.  38 
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Introduction 39 
Guidelines advise against antipsychotics for the first-line management of behavioral and 40 
psychological symptoms of dementia (BPSD),1,2 due to the increased risks of stroke and 41 
mortality.3-5 However, antipsychotics can be appropriate when behavioral symptoms are 42 
severe, dangerous, or distressing to the person with dementia.1,2 Despite the existence of 43 
guidelines for over a decade and national level efforts to improve dementia care, 44 
antipsychotic prescribing is still common, especially in nursing home (NH) settings.6-8 Global 45 
estimates of antipsychotic prescribing prevalence in NH residents vary from 16% in the US,9 46 
19% in England,6 to 27% across Western Europe.7 47 
A systematic review examining the effectiveness of interventions to reduce inappropriate 48 
prescribing of antipsychotics to NH residents with dementia, reported that the majority of 49 
interventions were effective in the short-term.10 However the long-term effects were 50 
assessed in only four studies, with prescribing returning to baseline levels in two studies.11,12  51 
Successful implementation of evidence-based practice requires effective and sustained 52 
behavior change, beginning with a thorough understanding of the problem.13 A body of 53 
qualitative research has explored problematic clinical decision-making in this area. We 54 
recently published a systematic review of this literature, and found that the use of 55 
antipsychotics in NHs is the culmination of a range of healthcare professional behaviors.14 56 
The two main behaviors identified were appropriate requesting and prescribing of 57 
antipsychotics. However, there has been a lack of exploration of these behaviors as 58 
standalone processes and in terms of how they influence each other. Furthermore, there 59 
has been limited exploration of how different stakeholders perceive these interacting 60 
4 
 
behaviors. Hence gaps in our understanding remain, which will be best answered by further 61 
qualitative research.  62 
The Theoretical Domains Framework (TDF) is an integrative framework of influences on 63 
behavior, identified by synthesizing multiple behavior change theories.15 The TDF consists of 64 
14 domains (Table 1), and provides a comprehensive, theory-informed approach to 65 
identifying the determinants (i.e. barriers and facilitator) which influence clinical 66 
behaviors.15 Utilization of the TDF will help us to identify the determinants which influence 67 
prescribing behaviors and hence support progression from exploration to intervention.16  68 
The aim of this qualitative study was to explore and interpret the determinants of 69 
appropriate prescribing behaviors (requesting and prescribing) among a range of individuals 70 
involved in the care of NH residents with dementia, with a view to informing future quality 71 
improvement efforts and behavior change interventions.   72 
Methods 73 
Study design 74 
We conducted semi-structured interviews, based on the TDF, with a range of healthcare 75 
workers and family members involved in the care of NH residents with dementia, in Cork, 76 
Ireland. Ethics approval was granted by the local ethics committee. The consolidated criteria 77 
for reporting qualitative research (COREQ) statement guided study reporting 78 
(Supplementary Table S1).17 Two Patient and Public Involvement (PPI) advisory groups 79 
composed of four people with dementia in one group, and two family members in the other 80 
group, provided input into topic guide development and recruitment. Advisor eligibility 81 
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criteria included being a person with dementia affiliated with the Alzheimer Society of 82 
Ireland or a family member of any NH resident with dementia, and having an interest in 83 
research aimed at improving the quality of medication usage in NHs. Written informed 84 
consent was obtained from all advisors. 85 
Study setting and sampling  86 
NHs were chosen as the focus of this study as the prevalence of antipsychotic use is highest 87 
in these settings.18,19 Participants were purposively sampled to ensure a heterogeneous 88 
group with maximum variation according to two main pre-determined criteria 89 
(Professional/social role and NH type) (Supplementary Table S2). We also used snowball 90 
sampling to fulfil our sampling framework requirements. 91 
Six different NH sites were selected based on our sampling framework, through publicly 92 
available directories of registered NHs on the Health Information and Quality Authority 93 
(HIQA)20 and Nursing Home Ireland websites.21 The Directors (Nursing or Medical) of each 94 
NH were contacted about the study. Once access was agreed, the Director and other 95 
consenting participants connected to that NH were interviewed. The Directors approached 96 
family members initially before recommending that they were suitable to be contacted.  97 
Eligibility criteria for healthcare workers included being a physician (general practitioner 98 
[GP], geriatrician or psychiatrist of old age), a nurse, a pharmacist or a healthcare assistant 99 
(HCA) who was involved in the care of NH residents with dementia. Eligibility criteria for 100 
family members included being a relative of a NH resident with dementia (alive or 101 
deceased), who had been prescribed an antipsychotic for BPSD.  102 
Data collection 103 
6 
 
We developed separate topic guides for healthcare professionals, HCAs and family 104 
members. Topic guides were iteratively developed using findings from our systematic 105 
review,14 the TDF, advisor recommendations and five pilot interviews. The topic guides 106 
underwent revisions throughout the study (Supplementary Table S3), to ensure that 107 
emerging themes were captured in subsequent interviews. All interviews were conducted 108 
by the primary author. Written informed consent was obtained prior to interviews. All 109 
interviews were audio-recorded and transcribed verbatim. The author wrote detailed field 110 
notes immediately after interviews, to refine topic guides and inform data analysis. We 111 
sampled until no new ideas emerged and conducted three more interviews without any new 112 
ideas emerging to ensure that data saturation had been reached.22 The interviews were 113 
conducted between July 2016 and April 2017. 114 
Data Analysis 115 
Data analysis followed the principles of Framework Analysis,23  and utilized NVivo version 116 
11.24 Data collection and analysis phases occurred concurrently, to enable the exploration of 117 
emergent themes in subsequent interviews and to identify when data saturation occurred.22 118 
We utilized both inductive and deductive approaches to analysis. A detailed description of 119 
the analysis is available online (Supplementary Material S4). In summary, we familiarized 120 
ourselves with each transcript and coded emerging concepts inductively. Simultaneously, 121 
we coded data from the transcripts into one or more TDF domains according to the 122 
definitions for each domain (Table 1).  We then created distilled summaries of each 123 
interview, to identify the predominant TDF domains and the determinants (i.e. barriers and 124 
facilitators) of the target behaviors (appropriate requesting and prescribing).16 Finally, we 125 
developed a conceptual model of explanatory findings, by exploring possible relationships 126 
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between determinants, predominant domains, categories and theory (Figure 1). In essence, 127 
the behavioral determinants were the ‘building blocks’ for the explanatory themes, and an 128 
overarching theme was identified, explaining the relationship between determinants and 129 
explanatory themes. The research group (consisting of pharmacists, a GP, a health 130 
psychologist, a methodologist and a geriatrician) held regular meetings throughout the 131 
study to discuss differences in interpretation and to identify themes.  132 
Results 133 
We invited six NHs to participate and four agreed - two private NHs, one with and one 134 
without a dementia special care unit (SCU); one voluntary NH (state-funded but charitable 135 
organization governance) without a SCU; and one public NH (state-run) without a SCU. Of 38 136 
individuals contacted, 27 agreed to participate (eight nurses, five GPs, five HCAs, three 137 
family members, two pharmacists, two consultant geriatricians and two consultant 138 
psychiatrists of old age) (Table 2). The median interview length was 23 minutes (range 12-56 139 
minutes). 140 
We identified nine predominant TDF domains, encompassing 38 behavioral determinants 141 
that influenced our target behaviors (Table 3). We also developed three explanatory themes 142 
and one over-arching theme, which are discussed below and illustrated in a conceptual 143 
model (Figure 1). The nine predominant TDF domains and the more seminal determinants 144 
are discussed below; detail on the remaining determinants is presented in Table 3. 145 
 146 
Predominant TDF domains 147 
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Behavioral Regulation 148 
Participants believed that HIQA, the independent NH regulator in Ireland, has put 149 
antipsychotics under scrutiny. Regulation now requires NHs to notify HIQA, on a quarterly 150 
basis, of any occasion when restraint (chemical or physical) is used.25 Some participants 151 
believed that these regulations made them re-evaluate how they manage BPSD, with 152 
positive outcomes for residents.  153 
“I think HIQA is brilliant... because I really think they force people to look at their 154 
practice, and to challenge their own practice and to change.” [HCA 1] 155 
However, GPs in particular, felt that there was over-regulation by HIQA, resulting in 156 
increased administrative burden, which did not necessarily translate into good care. 157 
Furthermore, some participants were confused by the regulatory requirements, and were 158 
concerned about unintended negative consequences, because of the mistaken belief that 159 
only psychotropic medications used for acute episodes were reportable.  160 
“Now, conversely, what it has made some nursing homes do is, if somebody was on a 161 
PRN psychotropic, because the resident might only need it once or twice per month 162 
and because it becomes reportable, they get prescribed regularly.” [Nurse 5] 163 
Healthcare workers reported that interdisciplinary medication reviews, audits and internal 164 
registries also provided an opportunity for self-monitoring. When in place, these systems 165 
assisted with the identification of patterns of inappropriate usage. Prescribers found 166 
international guidelines helpful in their decision-making.2 However, succinct guidelines 167 
specific to the Irish context were sought. 168 
Beliefs about Capabilities 169 
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Participants struggled to find solutions to BPSD other than antipsychotics in part because 170 
they felt that they lacked necessary training. NH staff struggled with the daily management 171 
of BPSD and some admitted that they needed antipsychotics to cope. GPs often felt out of 172 
their comfort zone and regularly needed input from specialists.  173 
“In some ways I don’t feel I have the sufficient expertise to make those decisions so 174 
I’ll look to specialists at that point if I’m struggling with something.” [GP 3] 175 
Beliefs about Consequences 176 
Both healthcare workers and family members were worried about side effects such as 177 
sedation and falls. Some viewed these side effects as undignified and inhumane, and hence 178 
were reluctant to request or prescribe antipsychotics.  179 
A fear of negative consequences (i.e. adverse behavioral events from residents) if 180 
antipsychotics were not prescribed was expressed by prescribers. They were conscious of 181 
the safety of their NH colleagues who were often at the receiving end of behaviors.   182 
“Because you don't know what precipitated the [behavior], and then, when you're 183 
trying to pull back and you walk away, are you leaving your colleagues in the height 184 
of it then?” [GP 4] 185 
 186 
Emotion 187 
Participants, particularly family and NH staff, spoke emotively about BPSD, and how these 188 
symptoms deeply impacted upon them personally. Sometimes participants believed that 189 
antipsychotics were the only solution to alleviating this distress. 190 
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“It was very hard to listen to [the BPSD]… so as far as I’m concerned, if there was a 191 
medication that would sort this thing anyway, I certainly was completely open to it.” 192 
[Family member 2] 193 
NH staff were deeply affected by behaviors leading to burn-out, frustration and poor 194 
morale. Staff sometimes took behaviors personally, which could increase the propensity to 195 
request prescribing of antipsychotics. Empathy as opposed to sympathy was viewed as an 196 
important trait when dealing with BPSD. It was seen to be important to be able to step back, 197 
evaluate the situation and determine the best course of action for the resident, without 198 
emotions clouding one’s judgement.  199 
“I feel that certain people take huge offence if a person who is cognitively impaired 200 
lashes out, punches, screams, whatever, and you have to let it go.” [Nurse 8] 201 
Environmental Context and Resources 202 
The overall picture was one of poor resources in NHs. Although non-pharmacologic 203 
interventions were generally seen as the gold standard, there was consensus that these 204 
interventions were staff-intensive and not always feasible. 205 
“You need to have the time to be with somebody, staffing levels don’t really give you 206 
the opportunity to sit with somebody all day long or all afternoon… you can come 207 
and go but you can’t stay with the person.” [Nurse 4] 208 
The physical environment was believed to have a profound impact on residents. Some 209 
participants believed that if the environment was better suited to meet the needs of the 210 
resident, then there would be less of a need to prescribe. 211 
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“I think if we had properly designed purpose built modern dementia units that 212 
allowed us to offer a different environment than the standard ward environment…  I 213 
do think that would be far more humane and you’ll probably get better overall results 214 
than resorting to the old fashioned chemical restraints.” [Consultant geriatrician 2] 215 
Participants described how treatment culture impacted on the resident in terms of 216 
prescribing, both positively (e.g. being resident-centered) and negatively (e.g. being task-217 
orientated). There was a general agreement that every NH was completely different, and 218 
what may be acceptable in one NH may not be acceptable in another. 219 
Knowledge 220 
Both healthcare workers and family members were aware that antipsychotics cause side 221 
effects. However, non-consultants in particular, acknowledged their own limited knowledge 222 
on this topic, and welcomed further education. Furthermore, GPs believed that a better 223 
understanding of the risk/benefit profile among NH staff would reduce requests for 224 
antipsychotics.   225 
“If you can tell someone what the potential complications [of antipsychotics] are, 226 
they may be a little bit less likely to ask for them.” [GP 1] 227 
In-depth knowledge of the resident was believed to be paramount. Knowing the resident 228 
and understanding their life story helped NH staff to adapt the environment to meet the 229 
needs of the resident, and often prevented unnecessary prescribing.  230 
“I think just knowing the person.  Knowing that they have been on them 231 
[antipsychotics] for years.  Looking at them now, their state of deterioration and you 232 
know in your heart and soul they don't need them.” [Nurse 5] 233 
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Memory, attention and decision-processes 234 
The importance of conducting a holistic assessment of the resident was emphasized by 235 
participants. There was agreement that antipsychotics were only appropriate after all 236 
potential reversible causes of BPSD were ruled out. In one NH, where a comprehensive 237 
assessment protocol was recently introduced, nurses explained how this protocol assisted 238 
them with their decision-making. 239 
Social Influences 240 
Prescribers were based off-site so relied on accurate and objective information about 241 
residents from nurses. Prescribers largely valued and trusted the nurses’ judgements and 242 
tended to make prescribing decisions based on the information provided. However this 243 
could lead to a perception that behavioral symptoms were being exaggerated in order to 244 
increase the likelihood of prescription. 245 
“I think people can be a little bit biased in how they can present a case to you at 246 
times to get to the ends that they want. I know there has been one incident where… a 247 
staff member [was overheard] saying ‘sure just tell her she’s had hallucinations.’” [GP 248 
3] 249 
Prescribers reported that pressure to prescribe antipsychotics arose from many sources 250 
including individual staff members, family members, the NH organization, and from society 251 
itself. 252 
“So I feel under pressure to knock this person out, anesthetize this patient, who they 253 
see as, shouldn't be challenging.  And they're already completely over-sedated and 254 
the staff want them to be even more sedated.”  [Consultant psychiatrist of old Age 2] 255 
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There was a perception by some of a prevailing culture where all behaviors may be 256 
attributed to the disease rather than an unmet need. However, other participants felt that, 257 
due to the influence of HIQA, NHs were moving toward a more social model of care. This 258 
shift in culture was broadly welcomed. However, some physicians feared that the pendulum 259 
had “swung too far” [Consultant psychiatrist of old age 1], and that GPs, in particular, may 260 
be fearful of using antipsychotics due to the perceived anti-medication climate. 261 
Social/Professional Role and Identity 262 
NH staff and family members viewed themselves as the resident’s advocate. This role 263 
empowered them to speak up on behalf of the resident. 264 
“See mom didn’t have a voice, nobody would listen to her even when she was 265 
speaking, she wasn’t listened to and I was her voice.” [Family member 1] 266 
There was a hierarchy described by participants in the NH environment. HCAs were often 267 
not involved in any degree of decision-making despite their in-depth knowledge of 268 
residents. Furthermore, one pharmacist felt disregarded in this area, despite her 269 
pharmacologic expertise. Decisions were perceived as being made between GPs and nurses, 270 
with input from consultants when needed.  271 
“As it stands and we're talking about the real world, it's really the nursing staff and 272 
the GP.  I don't have an influence there.  If I get the script, we just have to hand it 273 
over.” [Pharmacist 2] 274 
The importance of leadership from the NH manager was emphasized. Good leaders were 275 
perceived as those with experience who provided adequate training and support to staff.  276 
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Explanatory themes 277 
We identified “a fine balance” [HCA 1] as the over-arching theme. On one hand, neither 278 
healthcare workers nor family members wanted to see residents over-sedated and without 279 
a quality of life. Conversely, the reality of needing to protect staff, family members and 280 
residents from potentially dangerous behavioral symptoms, in a resource-poor 281 
environment, was emphasized. We found that NH staff and prescribers struggled with this 282 
constant tension throughout their daily practice.  283 
Beneath the over-arching theme of “a fine balance”, we developed three explanatory 284 
themes as a means of illustrating why this implementation issue, non-adherence to best-285 
practice guidelines, persists. Within these themes, opposing perspectives and trade-offs 286 
were evident which can tip the “fine balance” in favor of undertaking one behavior over 287 
another (e.g. prescribe versus not prescribe). We argue that the perspective of each NH 288 
toward these three explanatory themes, determines how they strike this “fine balance” 289 
(Figure 1). 290 
Human Suffering 291 
Participants described suffering related to both the disease and antipsychotic medications. 292 
Some viewed dementia as a terrible affliction: “I think it’s the hardest disease out there, to 293 
manage. It’s one I would NOT like to get myself” [HCA 2]. Not only was dementia perceived 294 
to cause suffering to the resident, but often participants reported being physically and 295 
emotionally affected themselves. Antipsychotics were viewed through this perspective as a 296 
way of alleviating suffering for everyone. Conversely, others acknowledged that 297 
antipsychotics can cause severe side effects for the resident, and were used primarily for 298 
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“staff-focused” [Consultant psychiatrist of old age 2] as opposed to resident-focused 299 
purposes. From this perspective, the use of antipsychotics were frowned upon.  300 
The Interface between Resident and Nursing Home 301 
The perceived effect that the resident has on the NH, and vice versa, was the second 302 
explanatory theme. A resident exhibiting BPSD was perceived by some to have a negative 303 
impact on the NH environment, ultimately requiring additional staff and money: “They 304 
haven’t enough staff and they seem to think that the cheapest way is to dose them, and 305 
keep them quiet” [Family member 1].  From this perspective, antipsychotics were perceived 306 
as necessary to enable staff to care for all residents in an efficient manner. Conversely, the 307 
NH environment was perceived by others to have an important impact on the resident.  308 
From this perspective, placing the resident in “the right place” [Nurse 3], i.e. a more 309 
dementia-friendly environment, was perceived to be more beneficial to the resident than 310 
any medication. 311 
Power and Knowledge: Complex Stakeholder Dynamics 312 
The final theme refers to the complex interplay between the many different stakeholders 313 
involved in the care of residents. The symbiotic concepts of power and knowledge can help 314 
us to understand these complex stakeholder dynamics.  There were different types of 315 
knowledge valued by participants: knowledge of the disease, the drug and the resident. 316 
Often primacy was given to the latter. Hence from this perspective, nurses’ in-depth 317 
knowledge of residents legitimized their power to request that an antipsychotic be started 318 
or stopped: “The GP's will do it [deprescribe], no problem, we need to instigate it, and it's 319 
just the experience of knowing the person” [Nurse 5]. Conversely, others argued that those 320 
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in higher positions of power had knowledge that was more important (i.e. knowledge of 321 
drug and disease), in determining the best outcomes for residents: “Old age psych usually 322 
make a recommendation and then the GP will sign the prescription” [Nurse 8]. From this 323 
perspective, those in positions of power were perceived to have the most important 324 
knowledge in determining the appropriateness of antipsychotic prescribing. 325 
Discussion 326 
Using a novel multi-perspective approach, we have generated a deeper understanding of 327 
the behavioral components of antipsychotic use in NH residents with dementia, the 328 
professional interactions that occur between different stakeholders and the determinants of 329 
implementation of best-practice guidelines. Our findings highlight how implementing 330 
evidence-based practice in this area remains a significant challenge, despite advances in 331 
knowledge and stricter regulations. We identified that stakeholders strive to strike “a fine 332 
balance” but ultimately, as humans, are influenced by interacting emotional, environmental, 333 
organizational and societal issues.  334 
Comparison with Previous Research 335 
This study builds on the findings of our systematic review14 where we identified five key 336 
concepts influencing decision-making: organizational capacity; individual professional 337 
capacity; communication and collaboration; attitudes; and regulations and guidelines. In this 338 
current study, we found all of these concepts also play a role in implementing evidence-339 
based practice. With regards to organizational capacity, the fundamental issue of 340 
inadequate resources was discussed in almost all of our interviews. This current study also 341 
extends our understanding of the influence of regulations on practice. Our study confirms 342 
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the important role of regulations, but also highlights unintended negative consequences 343 
that may occur as NHs undertake various workarounds. Similar workarounds have been 344 
reported in the US, where increasing diagnoses of schizophrenia in NH residents have been 345 
observed, in a suspected attempt to exempt antipsychotics from regulatory reporting 346 
requirements.26 347 
We identified nine TDF domains that influenced our target behaviors which are similar to 348 
those found in previous TDF studies exploring prescribing behaviors for various 349 
conditions.27-31 The key difference is our identification of ‘emotion’ as a predominant 350 
domain which is absent in the majority of other prescribing studies.27-30 The emotional 351 
impact of BPSD on family members32  and NH staff33 is established in the literature. The 352 
concept that people with dementia inevitably lose their identity to dementia and thus 353 
become ‘dehumanized’ has been hypothesized as a rationale for why family members often 354 
struggle with BPSD.32  In our study, this fear of dementia emerged as an important issue. It is 355 
evident that this impacts not only on family members, but also NH staff. Prescribers believe 356 
that sometimes it is challenging to decipher who precisely is distressed by the BPSD.  357 
Foucault wrote that power and knowledge are not independent entities but are inextricably 358 
linked — ‘knowledge is always an exercise of power and power always a function of 359 
knowledge’.34  This theory may help us to understand the complex dynamics between 360 
hierarchical stakeholders and how different types of knowledge are valued by different 361 
stakeholders.  Knowledge of the resident tends to be prioritized, and sometimes this can 362 
contradict with treatment goals set by those in higher positions of power (with different 363 
types of knowledge). Hence, advocating on behalf of the resident, particularly by nurses, is 364 
central to decision-making, and a key target for potential intervention.35,36  365 
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Previous studies have explored the challenges GPs experience when managing BPSD.37-39  366 
Jennings et al. identified three main challenges:  lack of clinical guidance; stretched 367 
resources; and difficulties managing expectations.37 Our study corroborates these findings 368 
by highlighting the multitude of difficulties GPs face when deciding whether to prescribe 369 
antipsychotics or not. However, our study goes further by exploring the perspectives of a 370 
wider range of stakeholders, allowing us to gain a more holistic insight into this 371 
implementation problem.  372 
Implications 373 
It is evident that greater policy and institutional support is required to help stakeholders 374 
strike that “fine balance” and ultimately make better prescribing decisions. Development of 375 
national clinical guidelines may be one appropriate policy intervention. Such guidelines are 376 
currently being developed in Ireland as a priority action point of the national dementia 377 
strategy.40 An important implication of our study is the need to clarify existing regulations 378 
for stakeholders, as it is evident that they are unsure as to which prescribing scenarios are 379 
reportable and which are not, and residents may be adversely affected by this confusion. 380 
Further consideration should also be given to the design of future NHs. Our findings 381 
highlight the importance stakeholders attribute to dementia SCUs in terms of meeting the 382 
needs of residents with dementia. However, resident outcomes from SCUs have been 383 
mixed, along with concern over higher levels of antipsychotic usage.41,42 Therefore, although 384 
SCUs may be desired by stakeholders, more evidence of the quality and safety of this 385 
approach is required before widespread adoption.  386 
The perceived impact of treatment culture on antipsychotic usage featured heavily 387 
throughout this study. In line with previous systematic review findings,14,43 the NH manager 388 
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was seen as a key determinant of NH treatment culture, as they possessed both a position 389 
of power and knowledge of the resident. We recommend that NH managers take advantage 390 
of their influential role by providing/organizing ongoing training to staff as well as 391 
encouraging the involvement of peripheral stakeholders (i.e. HCAs, pharmacists, family 392 
members) in decision-making. 393 
Despite guidance on avoiding antipsychotics in dementia, they can play an essential role in 394 
certain situations.1,2 Our study shows that due to the stigma attached to antipsychotics, 395 
some prescribers are fearful of prescribing them at all, risking unnecessary distress for a 396 
resident for whom the medications are indicated. A recent study demonstrated that 397 
discontinuation of antipsychotics, without non-pharmacologic substitution, can have a 398 
detrimental impact on residents’ health-related quality of life.44 Our findings suggest that an 399 
evidence-based, standardized approach involving interdisciplinary collaboration, careful 400 
documentation and regular review is needed to ensure the most appropriate use of both 401 
pharmacologic and non-pharmacologic interventions.45 One such model program is the DICE 402 
(describe, investigate, create, and evaluate) approach, which promotes a holistic, person-403 
centered approach to managing BPSD.45,46   404 
Educational programs are the most common intervention type utilized to tackle 405 
inappropriate antipsychotic prescribing10 e.g. the OASIS program47, the HALT study48 and the 406 
RedUSe project.11 Ongoing education and training to both NH staff and prescribers is an 407 
important aspect of ensuring appropriate antipsychotic prescribing, but is not sufficient on 408 
its own. Drawing from existing programs11,45,47,48 as well as our own findings, we 409 
recommend that future programs should include training on the assessment and 410 
management of BPSD, dealing with emotions and managing expectations. It is important for 411 
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prescribers to be empathetic and acknowledge the emotional and physical impact of BPSD, 412 
while assertively conveying, the limited benefit and serious risks associated with 413 
antipsychotics. Likewise, nurses as the key influencer on prescribing, should be aware of and 414 
communicate these issues to others within the NH and to family members. In  particular, the 415 
OASIS communication training program enforces these key messages.47 Future research 416 
should focus on determining how best to deliver educational interventions, and alongside 417 
what, in order to achieve sustainable results. 418 
Strengths and Limitations 419 
The trustworthiness of our findings are underpinned by the involvement of different 420 
disciplines on our research team and the participation of multiple stakeholders from 421 
different organizations during the interviews. Triangulation of analysts and participants also 422 
contributed toward the credibility of the results. Interviews took place in one region in 423 
Ireland, but transferability is supported by the provision of sufficient contextual information 424 
to enable readers to determine how applicable our findings are to their own situation. 425 
Detailed reporting of well-established methods with diagrammatical audit-trails contributed 426 
toward the dependability of our findings. Finally, in terms of confirmability, detailed 427 
reporting of participants’ quotations, helped ensure that our findings were primarily borne 428 
from the data.49 429 
Although 66% (4/6) of NHs and 71% (27/38) of individuals agreed to participate in our study, 430 
it is possible that only those with strong views on this topic took part. Furthermore, 431 
although we employed a purposive sampling approach, Directors may have recommended 432 
individuals for participation who were more likely to provide favorable responses about 433 
practices in their NH. Hence the possibility of selection bias cannot be excluded. Random 434 
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sampling of participants along with a larger sample may have reduced this problem, and 435 
may have allowed us to explore differences in perceptions between respondent groups and 436 
settings in greater detail.49 437 
Another limitation was the small number of family members recruited. The challenges of 438 
recruiting family members of residents with dementia to research studies have been 439 
previously reported.50 Despite engaging with our advisors on this issue, and reminding 440 
Directors to identify potential participants, we only managed to recruit three family 441 
members. It is possible that family members were apprehensive about taking part due to 442 
the emotive nature of this topic. Furthermore, it is possible that the Directors may have 443 
been over-protective of family members. 444 
Conclusions 445 
Implementing evidence-based antipsychotic prescribing practices for NH residents with 446 
dementia remains a significant challenge, despite advances in knowledge and stricter 447 
regulations. In striving to strike “a fine balance” stakeholders are influenced by interacting 448 
emotional, environmental, organizational and societal issues. Greater policy and 449 
institutional support is required to help stakeholders strike that “fine balance” and 450 
ultimately make better prescribing decisions. This study provides us with a deeper 451 
understanding of this complex issue and will inform the development of a theory and 452 
evidence-based intervention. 453 
 454 
 455 
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List of Figure Captions 629 
Fig. 1. Conceptual model of explanatory themes:  Opposing perspectives and trade-offs (in 630 
white) can tip the “fine balance” in favor of undertaking one behavior over another (e.g. 631 
prescribe versus not prescribe). The perspective of each nursing home toward these three 632 
explanatory themes (in blue), determines how they strike a “fine balance” between the risks 633 
and benefits of antipsychotics. 634 
 635 
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Knowledge of 
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takes 
precedence 
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power takes 
precedence 
Impact of the 
nursing home 
on the resident  
Fig. 1. Conceptual model of explanatory themes:  The perspective of each nursing toward these three explanatory themes (in blue), determines how they strike a “fine 
balance” between the risks and benefits of antipsychotics 
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Table 1 Theoretical Domains Framework (TDF) 637 
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 665 
 666 
 667 
Domain 
 
Definition 
Behavioral Regulation  
 
Anything aimed at managing or changing objectively observed 
or measured actions 
Beliefs about Capabilities 
 
Acceptance of the truth, reality, or validity about an ability, 
talent, or facility that a person can put to constructive use 
Beliefs about 
Consequences 
Acceptance of the truth, reality, or validity about outcomes of a 
behavior in a given situation 
Emotion 
 
A complex reaction pattern, involving experiential, behavioral 
and physiological elements, by which the individual attempts to 
deal with a personally significant matter or event 
Environmental Context and 
Resources 
 
Any circumstance of a person’s situation or environment that 
discourages or encourages the development of skills and 
abilities, independence, social competence, and adaptive 
behavior 
Goals Mental representations of outcomes or end states that an 
individual wants to achieve 
Intentions A conscious decision to perform a behavior or a resolve to act in 
a certain way 
Knowledge An awareness of the existence of something 
Memory, Attention and 
Decision-Processes 
The ability to retain information, focus selectively on aspects of 
the environment and choose between two or more alternatives 
Optimism 
 
The confidence that things will happen for the best or that 
desired goals will be attained 
Reinforcement 
 
Increasing the probability of a response by arranging a 
dependent relationship, or contingency, between the response 
and a given stimulus 
Skills An ability or proficiency acquired through practice 
Social Influences 
 
Those interpersonal processes that can cause individuals to 
change their thoughts, feelings or behaviors 
Social/Professional Role 
and Identity 
A coherent set of behaviors and displayed personal qualities of 
an individual in a social or work setting 
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Table 2 Characteristics of Interview Participants (n=27) 668 
* N/A for n=3 family members 669 
 670 
 671 
Characteristics of total participants (n=27) Participants, n  
Professional/social role  
Nurse 8  
General Practitioner 5  
Healthcare Assistant 5  
Family Member 3 
Pharmacist 2  
Consultant Geriatrician 2  
Consultant Psychiatrist of Old Age 2 
Gender  
Female  17 
Male 10 
Other 0 
Category of Nursing Home participant worked in*  
Private only 9  
Public only 4  
Voluntary only 3  
Multiple 8 
Years of professional experience (since qualification)*  
<10 years 3  
10-19 years 10  
≥20 years 10  
Information not provided 1  
Received specialist dementia training*  
Yes 16  
No 8 
Presence of dementia special care unit (SCU) in any nursing home participant 
worked in* 
 
Yes 7  
No 
 
17  
Characteristics of Family Member Participants (n=3) Participants, n 
Gender  
Female  2 
Male 1  
Other 0  
Category of Nursing Home person with dementia resides/resided  
Private  3  
Role  
Current carer 1 
Former carer 2  
Age of participant  
40-49 1  
50-59 1  
60-69 1 
Relationship to person with dementia  
Son/daughter 2  
Nephew/niece 1  
31 
 
Predominant 
TDF domain 
Determinants (i.e. barriers 
and/or facilitators) of 
appropriate antipsychotic 
prescribing behaviors 
Illustrative quotes 
Behavioral 
Regulation  
 
 
 
 • HIQA regulation as a 
stimulus for change 
(facilitator) 
• I think HIQA is brilliant... because I really think they force people to look at their practice, and to 
challenge their own practice and to change.” [HCA 1] 
 • Perception of HIQA over-
regulation by GPs (barrier) 
 
• “I think HIQA are a scurge. I wonder what they bring to the table. I think they’re self-fulfilling... Ya I 
think most GPs would not [be happy with them]. I don’t think they bring a whole lot to the table 
unfortunately. I think they bully private nursing home and private institutions…Ya I think it’s all 
very, very good and ivory tower stuff and politically correct. But, could I think [sic] the money spent 
on HIQA could be spent better on direct services? Probably.” [GP 1] 
 • Uncertainty regarding 
HIQA reporting requirements 
(barrier) 
• “Now, conversely, what it has made some nursing homes do is, if somebody was on a PRN 
psychotropic, because the resident might only need it once or twice per month and because it 
becomes reportable, they get prescribed regularly.” [Nurse 5] 
 • Self-monitoring (using 
local systems) of 
antipsychotic prescribing 
(facilitator) 
• “So, for me it would be to monitor the scripts as they come in and maybe their charts and we do at 
the request of the Director of Care, we do a psychotropic audit every month.  So we see where 
they're being reviewed.” [Pharmacist 2] 
 
 • Guidelines for 
monitoring the 
appropriateness of 
antipsychotic prescribing 
(facilitator) 
• “Guidelines is a good thing, and licensing, because you know there isn't any license.  Grade one, 
grade two evidence, meta-analyses… You can certainly use them to say why you're not prescribing 
an antipsychotic.  You just say there's no evidence and it's not national policy.” [Consultant 
Psychiatrist of Old Age 2] 
Beliefs about 
capabilities 
  
 • Poor self-efficacy in the 
management of BPSD among 
non-specialists (barrier) 
• “So I suppose in some ways I don’t feel I have the sufficient expertise to make those kind of 
decisions so I’ll look to specialists at that point if I’m struggling with something.” [GP 3] 
 • Belief that assessing 
whether an antipsychotic 
prescription is ‘appropriate’ 
or not is challenging (barrier)  
• “It's a difficult one to decipher.  When it's appropriate and when it's not appropriate.” [Nurse 6] 
 
 • Belief that deprescribing 
antipsychotics is difficult 
(barrier) 
• “And it’s very easy starting these things but the discontinuation of them not quite so clear cut.” 
[Consultant Geriatrician 2] 
Beliefs about 
consequences 
  
 
 • Concerns about side-
effects (facilitator) 
• “She was just asleep looking, absolutely drugged out of her tree looking, sitting in a chair.” [Family 
member 1] 
 • Belief that antipsychotics 
are highly effective (barrier) 
• “I know the drugs can fix these things. Now not completely right. But I know that drugs can fix 
these things.” [Family member 2] 
 • Belief that NPIs are not a 
feasible alternative (barrier) 
• “But if you have somebody at 2 o clock in the morning that you’re pacing the floor with until 6 o 
clock in the morning, where are your therapies then?” [HCA 2] 
 • Belief that the return of 
symptoms are caused by the 
reduction of antipsychotic 
dosage (barrier) 
• “I think people often think, that if something doesn’t work straight way or if there happens to be a 
coincidental problem as soon as you start to reduce it, suddenly there is this complete fear that this 
has caused it they expect more immediate, they see the immediate things as being either absent or 
present so when you start a new drug if it hasn’t worked straight away there is a bit of ‘oh it’s not 
working.’” [GP 3] 
 • Anticipated regret 
(barrier) 
• “Because you don't know what precipitated the [behavior], and then, when you're trying to pull 
back and you walk away, are you leaving your colleagues in the height of it then?” [GP 4] 
Emotion   
 • Fear of dementia 
(barrier) 
• “It was very hard to listen to [the BPSD]… so as far as I’m concerned, if there was a medication that 
would sort this thing anyway, I certainly was completely open to it.” [Family member 2] 
 • Taking behaviors 
personally (barrier) 
• “I feel that certain people take huge offence if a person who is cognitively impaired lashes out, 
punches, screams, whatever and you know, you have to let it go.” [Nurse 8] 
 • Burn-out and frustration 
(barrier) 
• “You’ll get staff who are burned out, they just can’t cope.  They’re sick of saying X, Y and Z and 
they’re not being listened to, and they just don’t care anymore.” [Nurse 3] 
Table 3 Determinants of appropriate antipsychotic prescribing behaviors (requesting and prescribing) 
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 • Empathy toward people 
with dementia (facilitator) 
 
• “I think people with a very empathetic view of dementia would be less likely to encourage, 
prescription of antipsychotics, because there is that, ‘oh it's, you know, you don't have to give them 
drugs for it, it's just their dementia, we can get around it,’ and then, some people… will see the 
more negative side of the dementia, and be like, ‘isn't it awful for them, God wouldn't you just give 
them something to relax them.’ [Nurse 6] 
 • Emotions of healthcare 
professionals tend to reflect 
those of family members 
(barrier) 
• “I’ll get [a phone call], ‘The family were in today they’re very worried about mammy. She’s very 
upset and agitated’. I never get those phone calls to say that they’re worried that’s she’s just sitting 
there staring into space.” [GP 1] 
 • Personal experience of 
dementia 
(barrier/facilitator)* 
• “We’re all human, we all bring our own stuff.” [HCA 3] 
Environmental 
Context and 
Resources 
  
 
 • Lack of adequate 
resources (barrier) 
• “You need to have the time to be with somebody, staffing levels don’t really give you the 
opportunity to sit with somebody all day long or all afternoon… you can come and go but you can’t 
stay with the person.” [Nurse 4] 
 • Perception that it’s 
cheaper to give 
antipsychotics than deliver 
NPIs (barrier) 
• “They haven’t enough staff and they seem to think that the cheapest way is to dose them, and keep 
them quiet” [Family member 1].   
 • Impact of the built 
environment on the person 
with dementia (facilitator/ 
barrier)* 
• “I think if we had properly designed purpose built modern dementia units that allowed us to offer a 
different environment than the standard ward environment…  I do think that would be far more 
humane and you’ll probably get better overall results than resorting to the old fashioned chemical 
restraints.” [Consultant geriatrician 2] 
 • Each nursing home is 
different (facilitator/barrier)* 
• “You go to different nursing homes and attitudes are very different.” [Nurse 3] 
 
 • Impact of treatment 
culture on residents 
(facilitator/barrier*) 
• “Sometimes it can feel like the person is there as…  I don't know how to say this politely, but they're 
in the bed and they have to acquiesce or be compliant with the system around them, be good 
children or good grown-ups and play the game.  And if you don't do that, then you get labelled and 
your behavior gets labelled.” [Consultant Psychiatrist of Old Age 1] 
Knowledge   
 • Knowledge of 
antipsychotics (facilitator) 
• “If you can tell someone what the potential complications [of antipsychotics] are, they may be a 
little bit less likely to ask for them.” [GP 1] 
 • Knowledge on the cause 
and nature of BPSD 
(facilitator) 
• “I think if people understood… why [residents] have behaviors that challenge I think that would go a 
long way for a lot more understanding and people not wanting just to sedate somebody.” [Nurse 3] 
 • Knowledge of the 
resident (facilitator) 
• “I think just knowing the person.  Knowing that they have been on them [antipsychotics] for years.  
Looking at them now, their state of deterioration and you know in your heart and soul they don't 
need them.” [Nurse 5] 
Memory, 
attention and 
decision-
processes 
  
 
 • Decision-making based 
on a thorough assessment 
(facilitator) 
• “Then with the physical as well, we do the PINCH ME acronym so we...pain, infection, constipation, 
hydration, nutrition, medications, environment, we look at real holistic view of the person and try 
and rule out any triggers there [sic].”  [Nurse 6] 
 • Paying attention to 
where the challenge lies with 
regards to the behavioral 
symptoms (facilitator) 
• “Sometimes it just ultimately again it takes me back, you need to take a step back, who are you 
treating? Are you treating the carer who wants a certain amount given so somebody is peaceful or 
a certain amount of investigation is done, or are we treating the staff who are treating the patient 
because they want a peaceful night or a peaceful day on the ward, or are we making a decision to 
make our own lives easier. And we just have to take a step back sometimes.” [GP 5] 
Social 
Influences 
  
 • Social Pressure to 
prescribe (barrier) 
• “So I feel under pressure to knock this person out, anesthetize this patient, who they see as, 
shouldn't be challenging.  And they're already completely over-sedated and the staff want them to 
be even more sedated.”  [Consultant psychiatrist of old Age 2] 
 • Reliance on accurate 
information from nursing 
home staff 
(facilitator/barrier)* 
• “I think people can be a little bit biased in how they can present a case to you at times to get to the 
ends that they want. I know there has been one incident where… a staff member [was overheard] 
saying ‘sure just tell her she’s had hallucinations.’” [GP 3] 
33 
 
 • Modelling of prescribing 
behavior (facilitator/barrier)* 
• “A lot of our learning seems to come from the consultations and referrals that we actually see what 
the psychiatry of the elderly prescribe in these situations, and we have been led by that, so 
quetiapine just seems to be one they seem to use.” [GP 5] 
 • Prevailing culture of care 
(facilitator/barrier)* 
• “Medication comes first in Ireland. ‘Give it to them as much as possible’”. [Family member 1] 
Social/ 
Professional 
Role and 
Identity 
 
 
 
 
 
 • Advocacy role of nursing 
home staff and family 
members (facilitator) 
• “See mom didn’t have a voice, nobody would listen to her even when she was speaking, she wasn’t 
listened to and I was her voice.” [Family member 1] 
 • Professional identity 
(facilitator/barrier)* 
 
• “It depends on what background you are coming from and when you trained, how you view the 
medications and the use of medications.  I think there is a difference, between the younger 
generation of nurses and the older generation of nurses.  There appears to be more of a reluctance, 
I think, in the younger generation of nurses with giving out, I suppose the high risk medications like 
[antipsychotics]…  And I think there is a difference there then because you're not seeing your 
nursing profession as a medical profession, you’re almost a facilitator...and when you see it from 
that perspective then medication isn't always the first kind of thing that pops into your head.” 
[Nurse 6] 
 • Variable sense of 
responsibility for prescribing 
decisions 
(facilitator/barrier)* 
• “But I suppose it’s up to the prescriber to be able to sort the wheat from the chaff and see what’s a 
good grounded opinion and what’s maybe not as reliable you know.” [HCA 3] 
 
 • Leadership role of 
nursing home manager 
(facilitator) 
 
• “You need a manager who is supporting staff and is knowledgeable and roles out good training to 
the staff.  And has good experience so, and ideally good mental health experience because that's, 
not all of them have good mental health experience but it is important for the manager, if you meet 
the manager, you can usually see the tone of the home.” [Consultant Psychiatrist of Old Age 2] 
 • Traditional hierarchy 
(barrier) 
• “As it stands and we're talking about the real world, it's really the nursing staff and the GP.  I don't 
have an influence there.  If I get the script, we just have to hand it over.” [Pharmacist 2] 
* This determinant could be a barrier or a facilitator depending on the individual circumstance 672 
BPSD: Behavioral and Psychological Symptoms of Dementia; GP: General Practitioner; HCA: Healthcare assistant; HIQA: 673 
Health Information and Quality Authority; NPIs: Non-pharmacological interventions; TDF: Theoretical Domains Framework 674 
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